2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8+ T cell responses.

Area of Science:

• Immunology
• T cell biology
• Immune regulation

Background:

• T cell activation outcomes are influenced by co-stimulatory and co-inhibitory receptors.
• Understanding these interactions is key in autoimmunity and chronic viral infections.

Purpose of the Study:

• To investigate the role of the co-inhibitory receptor 2B4 (CD244) in CD8(+) T cell responses during immune modulation.
• To determine the impact of CD28 blockade on 2B4 (CD244) expression and function.

Main Methods:

• Utilized animal models with selective CD28 blockade and CTLA-4 Ig treatment.
• Analyzed antigen-specific CD8(+) T cell responses in the presence and absence of 2B4 (CD244).
• Assessed 2B4 (CD244) expression levels on T cells under different immune modulation conditions.

Main Results:

• Selective CD28 blockade led to specific up-regulation of 2B4 (CD244) on antigen-specific CD8(+) T cells.
• This up-regulation was not observed with CTLA-4 Ig or combined CD28 blockade and anti-CTLA-4 treatment.
• CD8(+) T cell responses were attenuated when 2B4 (CD244) was deficient during CD28 blockade, indicating functional significance.

Conclusions:

• Blockade of CD28 signaling, with preserved CTLA-4 signaling, uniquely up-regulates 2B4 (CD244) on primary CD8(+) effector T cells.
• This 2B4 (CD244) expression plays a critical role in controlling antigen-specific CD8(+) T cell responses.
• 2B4 (CD244) deficiency did not affect T cell responses during unmodified rejection or with CTLA-4 Ig treatment.